Changes in histamine content following pharmacologically-induced mast cell degranulation in the rat conjunctiva.
Compound 48/80 was applied into one eye of male Wistar rats and a drop of vehicle into the contralateral eye. Another group of rats received sodium cromoglycate in both eyes every 6 h for a period of 48 h. One eye was challenged with compound 48/80 30 min after the end of treatment with sodium cromoglycate. The eyes were monitored clinically and the histamine content of the conjunctiva was determined fluorometrically. The basal histamine levels in rat conjunctival homogenates were quantified. Pharmacologically-induced mast cell degranulation by a single application of 0.1 g ml(-1)of compound 48/80 resulted in significant decreases of conjunctival histamine levels 1, 12 and 24 h after challenge. Sodium cromoglycate prevented the effect of compound 48/80 when administered into the eye prior to the challenge with the non-immunogenic histamine releaser. Upon termination of the application, the membrane stabilizer was unable to reverse the reduced histamine levels in the conjunctival homogenates.
Tiligada
E
E
Department of Experimental Pharmacology, Medical School, University of Athens, M. Asias 75, Athens, GR-11527, Greece.
Aslanis
D
D
Delitheos
A
A
Varonos
D
D
D000818:Animals; D015550:Cell Degranulation / Q000187:drug effects; D003228:Conjunctiva / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology; D003233:Conjunctivitis, Allergic / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology; D004205:Cromolyn Sodium / Q000494:pharmacology; D004195:Disease Models, Animal; D006632:Histamine / Q000378:metabolism*; D008297:Male; D008407:Mast Cells / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D017208:Rats, Wistar; D003189:p-Methoxy-N-methylphenethylamine / Q000494:pharmacology
D003189:p-Methoxy-N-methylphenethylamine; D006632:Histamine; D004205:Cromolyn Sodium